HeartCore Enterprises Authorizes $2 Million Share Repurchase
HeartCore Enterprises announced that its Board of Directors has authorized a share repurchase program pursuant to which the Company may repurchase up to $2.0 million of its outstanding shares of common stock. "We believe our current valuation should be considered in the context of our balance sheet strength and the strategic progress we have made over the past year," said HeartCore CEO Sumitaka Kanno. "Based on our preliminary internal estimates, our total net assets exceeded our current market capitalization, which we believe is an important factor when evaluating the Company's overall value. Over the past year, we have taken meaningful steps to reposition HeartCore-restructuring our business portfolio, sharpening our focus on financial consulting and Go IPO services, and improving our earnings profile. These developments support our confidence in the Company's long-term direction."
Trade with 70% Backtested Accuracy
Analyst Views on HTCR
About HTCR
About the author

- Reverse Stock Split Approval: HeartCore Enterprises' board has approved a 1-for-20 reverse stock split effective April 2, 2026, aimed at increasing the share price to meet Nasdaq's $1.00 minimum bid requirement for continued listing.
- Trading Changes: Following the reverse split, the company's common stock will trade under a new CUSIP number 42240Q 203 on Nasdaq starting April 6, 2026, marking a significant step towards compliance with listing standards.
- Market Reaction: Following the announcement, HTCR's stock price fell 22.87% in premarket trading to $0.173, indicating market caution regarding the split and potential impacts on investor confidence.
- Financial Outlook: HeartCore expects FY revenue between $8.5 million and $9.5 million, and despite facing stock price pressures, the company is striving for stable revenue growth.
- Disappointing Earnings: HeartCore's released earnings report indicates a FY GAAP EPS of -$0.17, missing expectations by $0.14, which reflects a significant decline in profitability and may negatively impact investor confidence.
- Revenue Decline: The company reported FY revenue of $9 million, representing a 60.4% year-over-year decline, indicating weak market demand that could lead to future liquidity issues.
- Cautious Outlook: HeartCore expects FY revenue to be between $8.5 million and $9.5 million, reflecting uncertainty about future market conditions that may affect its strategic planning and investment decisions.
- Market Reaction Anticipation: Given the disappointing earnings performance, investors may react negatively to HeartCore's stock price, further exacerbating concerns about its long-term growth potential.
- Share Repurchase Program: HeartCore Enterprises announced a plan to repurchase up to $2 million of its common stock, aiming to enhance earnings per share by reducing the outstanding share count, thereby boosting investor confidence and stabilizing the stock price.
- Stock Price Reaction: Following the announcement, HTCR's stock price rose 7.56% in premarket trading to $0.283, indicating a positive market response to the repurchase plan, which may attract more investor interest.
- Financial Outlook: HeartCore expects FY revenue to be between $8.5 million and $9.5 million, suggesting that the company maintains a stable revenue base in the current market environment, potentially laying the groundwork for future growth.
- Market Signal: By implementing the share repurchase, HeartCore signals confidence in its own value, which may also attract institutional investors' attention, further enhancing the company's image in the capital markets.
- Share Repurchase Program: HeartCore's Board has authorized a share repurchase program allowing for the buyback of up to $2 million in stock, reflecting management's view on the company's current valuation and long-term capital allocation priorities aimed at enhancing shareholder value.
- Asset vs. Market Capitalization: As of February 24, 2026, preliminary estimates indicate that HeartCore's total net assets exceed its market capitalization, an important factor in assessing the company's overall value and indicating strong financial health.
- Flexible Capital Allocation: The repurchase program will be executed through open market transactions and privately negotiated deals, with the timing and amount depending on market conditions and capital availability, showcasing the company's flexibility in capital allocation.
- Strategic Restructuring and Profit Outlook: This repurchase initiative follows the company's recent business restructuring and improved profitability outlook, demonstrating HeartCore's commitment to enhancing shareholder returns while focusing on financial consulting and IPO services.
- Revenue Outlook: HeartCore Enterprises anticipates FY 2025 revenue between $8.5M and $9.5M, indicating potential growth despite challenges from revenue decline.
- Strategic Divestiture Impact: The completion of the divestiture of wholly-owned subsidiary HeartCore Japan on October 31, 2025, will exclude approximately $7M to $8M from consolidated revenue, aimed at optimizing resource allocation.
- Profitability Improvement: Despite the revenue decline, HeartCore expects net income for FY 2025 to be between $3M and $4M, a significant turnaround from a net loss of $5.2M in the previous year, showcasing improved profitability.
- Asset Disposal Gains: The sale of HeartCore Japan resulted in a gain of approximately $7M, alleviating revenue decline pressures and providing financial resources for future investments and growth.








